Clinical Trial Update: Compound Staphylococcal Lysostaphin Vs. Chlorhexidine Mouthrinse for Oral Mucositis in Patients Undergoing Allo-HSCT [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Compound Staphylococcal Lysostaphin to chlorhexidine mouthrinse for oral mucositis in patients undergoing allogeneic hematopoietic stem …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complications of Stem Cell Transplantation
• Oral Mucositis

Drugs mentioned

• Compound Staphylococcal Lysostaphin (lysostaphin)

Snippet

Sponsor: Zhejiang University | Conditions: Stem Cell Transplant Complications, Oral Mucositis | Phase 3 | Status: COMPLETED